Active ingredients
Pharmacological Group
Used in the treatment of
- T14.0 Superficial injury of unspecified body region
- R07.2 Precordial pain
- M34 Systemic sclerosis
- M24.5 Contracture of joint
- M15-M19 Arthrosis
- M06.9 Rheumatoid arthritis, unspecified
- L98.4 Chronic ulcer of skin, not elsewhere classified
- L90.5 Scar conditions and fibrosis of skin
- L58 Radiodermatitis
- J40 Bronchitis, not specified as acute or chronic
- I21 Acute myocardial infarction
- G54.9 Nerve root and plexus disorder, unspecified
- A15-A19 Tuberculosis
- M72.0 Palmar fascial fibromatosis [Dupuytren]
- M25.6 Stiffness of joint, not elsewhere classified
- L87 Transepidermal elimination disorders
- H35 Other retinal disorders
- M48 Other spondylopathies